Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Jan 19, 2022 3:28pm
122 Views
Post# 34334323

RE:RE:Meetings with Large Holders

RE:RE:Meetings with Large HoldersYou are full of surprises....


SPCEO1 wrote: I am not attending either of the sessions. But I am friends with those shareholders and they will let me know what TH said. So, they will at least publish a new corporate presentation before using it with those shareholders, so I am expecting that we will all basically know the message they are willing to convey to shareholders generally before those meetings actually even happen. Those attending the meetings may be able to get further nuance about whatever is in the corporate presentation, but they will not get much more than the company has in the presentation and could easily misread the nuance they are thinking they are getting.

There is still a possibility that there is a PR on the phase 1a tomorrow or Friday morning but since the trial still seems to be in progress, that is looking less likely. I suppose there could be other PR's tomorrow or Friday or even Monday morning on other subjects (a Chinese cancer partner, another acquisition like the Katanna deal or a NASH partner, for example) but that seems less likely. It is too early for a cancer partnership, deals like Katanna are not common and they should probably not do anything on that front until they have firmed up what they ahve in cancer and a NASH partner is likely to remain elusive.

So, my best guess is we get a new corporate presentation on Friday and it does not shed a lot  of new light on the questions we would like to have answered. If so, the etremely, extremely patient and nice shareholders TH will be talking to early next week are likely to be less than thrilled with the lack of reported progress and the poor performance of the stock during the market bubble. The opportunity cost has been huge for TH shareholders and the ONO made them feel as though the company had taken advantage of them. So, the sooner TH can get good news out, the better for everyone. Hopefully, that will happen tomorrow or Friday but it does not smell like that to me. 

longterm56 wrote: If they don't put out a PR soon, I don't know what they will talk about with the large shareholders next week. They can't disclose anything that is not public ... and there is A LOT of info that is not public.

SPCEO, which day are you attending?

  -LT
 




<< Previous
Bullboard Posts
Next >>